01st October 2021 | Pharma Updates

MSD Pharma introduces HPV Vaccine in India

Merck Sharp & Dohme’s subsidiary MSD Pharmaceuticals has launched a gender neutral HPV vaccine in India.

Universal Medicare-Kedaara Capital consortium finishes purchase of Sanofi's nutraceutical business

Vikash Prasad has been appointed as the CEO.

SAVA Healthcare has invested Rs 200cr in India

The drug company has acquired 15 acres of land close to Smart Industrial Park in Madhya Pradesh.

Glenmark receives a nod to market Ryaltris

This nasal spray is indicated for the treatment of seasonal and perennial allergic rhinitis of 12 yrs above people.

Hyderabad based pharma leaders feature in top 100 India Rich List

Murali Divi of Divi Labs is the richest pharma executive and has a wealth of Rs.79000 cr.

Lupin, Glenmark Pharma, Cipla, Aurobindo potential winners to ride USD 183 billion cardiac segment

Cardiac accounts for a 13% share in the Indian pharma industry and is growing at a rate of 10% Compound Annual Growth Rate.

AIPSN expresses concern over WHO not granting emergency use listing for Covaxin

All India Peoples Science Network (AIPSN) has expressed concern over the World Health Organisation (WHO) not granting Emergency Use Listing (EUL) for Covaxin.